EHMT2 and cholangiocarcinoma: Additionally, c‐Myc was recently shown to mediate the recruitment of G9a to the promoter of 15‐hydroxyprostaglandin dehydrogenase to silence its expression through enhanced H3K9 methylation in cholangiocarcinoma [23].